BioSpace News Archive

Genetown

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 05, 2023

Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to an employee to purchase up to 35,000 shares of the Company’s common stock on January 3, 2023.

January 5, 2023
·
2 min read
Biotech Bay

CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

CytomX Therapeutics, Inc. and Moderna, Inc. announced a collaboration and licensing agreement to create investigational mRNA-based conditionally activated therapies utilizing Moderna’s mRNA technologies and CytomX’s Probody® therapeutic platform.

January 5, 2023
·
10 min read
Freeline Reports December 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 05, 2023

Freeline Therapeutics Holdings plc announced that on December 30, 2022, the Company granted four newly hired employees non-statutory options to purchase an aggregate of 48,900 of the Company’s ordinary shares.

January 5, 2023
·
1 min read
Business

Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced the appointment of Rita Jain, M.D., to the Company’s Board of Directors.

January 5, 2023
·
6 min read
Biotech Bay

Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference

Terns Pharmaceuticals, Inc. announced that management will provide an update on its pipeline and strategic priorities for 2023 during the Company’s presentation at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 at 9:00am PT.

January 5, 2023
·
9 min read
Biotech Bay

Helix and QIAGEN Form Exclusive Global Partnership to Develop and Commercialize Companion Diagnostics for Hereditary Diseases

Helix, the leading population genomics and viral surveillance company in the nation, announced a global strategic partnership with QIAGEN N.V., the leading global provider of Sample to Insight solutions, to jointly develop companion diagnostics for hereditary diseases.

January 5, 2023
·
5 min read
Business

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens.

January 5, 2023
·
1 min read
Drug Development

Renibus Therapeutics Announces Positive 30-Day Topline Data from RBT-1 Phase 2 Trial

Renibus Therapeutics® (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal diseases, today announced positive 30-day topline data from RBT-1 in a Phase 2 trial.

January 5, 2023
·
6 min read
BioMidwest

Halia Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Halia Therapeutics announced that David J. Bearss, Ph.D., CEO of Halia Therapeutics, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, at 07:30 a.m. PST/10:30 a.m. EST.

January 5, 2023
·
1 min read
Pharm Country

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2023

Rallybio Corporation provided an update on recent accomplishments and announced expected 2023 clinical milestones.

January 5, 2023
·
8 min read